Literature DB >> 29261341

Benefit requirements for substance use disorder treatment in state health insurance exchanges.

Bikki Tran Smith1, Kathleen Seaton2, Christina Andrews3, Colleen M Grogan1, Amanda Abraham4, Harold Pollack1, Peter Friedmann5, Keith Humphreys2.   

Abstract

BACKGROUND: Established in 2014, state health insurance exchanges have greatly expanded substance use disorder (SUD) treatment coverage in the United States as qualified health plans (QHPs) within the exchanges are required to conform to parity provisions laid out by the Affordable Care Act and the Mental Health Parity and Addiction Equity Act (MHPAEA). Coverage improvements, however, have not been even as states have wide discretion over how they meet these regulations.
OBJECTIVE: How states regulate SUD treatment benefits offered by QHPs has implications for the accessibility and quality of care. In this study, we assessed the extent to which state insurance departments regulate the types of SUD services and medications plans must provide, as well as their use of utilization controls.
METHODS: Data were collected as part of the National Drug Abuse Treatment System Survey, a nationally-representative, longitudinal study of substance use disorder treatment. Data were obtained from state Departments of Insurance via a 15-minute internet-based survey.
RESULTS: States varied widely in regulations on QHPs' administration of SUD treatment benefits. Some states required plans to cover all 11 SUD treatment services and medications we assessed in the study, whereas others did not require plans to cover anything at all. Nearly all states allowed the plans to employ utilization controls, but reported little guidance regarding how they should be used.
CONCLUSION: Although some states have taken full advantage of the health insurance exchanges to increase access to SUD treatment, others seem to have done the bare minimum required by the ACA. By not requiring coverage for the entire SUD continuum of care, states are hindering client access to appropriate types of care necessary for recovery.

Entities:  

Keywords:  ACA; MHPAEA; health insurance exchanges; qualified health plans; substance use disorder treatment

Mesh:

Year:  2017        PMID: 29261341      PMCID: PMC5940489          DOI: 10.1080/00952990.2017.1411934

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  3 in total

1.  The Affordable Care Act will revolutionize care for substance use disorders in the United States.

Authors:  Keith Humphreys; Richard G Frank
Journal:  Addiction       Date:  2014-06-26       Impact factor: 6.526

2.  How the affordable care act and mental health parity and addiction equity act greatly expand coverage of behavioral health care.

Authors:  Kirsten Beronio; Sherry Glied; Richard Frank
Journal:  J Behav Health Serv Res       Date:  2014-10       Impact factor: 1.505

3.  The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act.

Authors:  Jeffrey A Buck
Journal:  Health Aff (Millwood)       Date:  2011-08       Impact factor: 6.301

  3 in total
  4 in total

Review 1.  Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Authors:  Keith Humphreys; Chelsea L Shover; Christina M Andrews; Amy S B Bohnert; Margaret L Brandeau; Jonathan P Caulkins; Jonathan H Chen; Mariano-Florentino Cuéllar; Yasmin L Hurd; David N Juurlink; Howard K Koh; Erin E Krebs; Anna Lembke; Sean C Mackey; Lisa Larrimore Ouellette; Brian Suffoletto; Christine Timko
Journal:  Lancet       Date:  2022-02-02       Impact factor: 202.731

2.  Impact of health reform on health insurance status among persons who use opioids in eastern Kentucky: A prospective cohort analysis.

Authors:  Hannah K Knudsen; Michelle R Lofwall; Sharon L Walsh; Jennifer R Havens
Journal:  Int J Drug Policy       Date:  2019-05-01

3.  Factors associated with state legislators' support for opioid use disorder parity laws.

Authors:  Katherine L Nelson; Jonathan Purtle
Journal:  Int J Drug Policy       Date:  2020-06-12

4.  Private health insurance coverage of drug use disorder treatment: 2005-2018.

Authors:  Ramin Mojtabai; Christine Mauro; Melanie M Wall; Colleen L Barry; Mark Olfson
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.